• 1. Emerging investigator series: bacteriophages as nano engineering tools for quality monitoring and pathogen detection in water and wastewater
  Fereshteh Bayat Environ. Sci.: Nano, 2021,8, 367-389
• 2. Excellent mechanical performance and enhanced dielectric properties of OBC/SiO2 elastomeric nanocomposites: effect of dispersion of the SiO2 nanoparticles?
  Xing Zhao,Lu Bai,Rui-Ying Bao,Zheng-Ying Liu,Ming-Bo Yang,Wei Yang RSC Adv., 2017,7, 46297-46305
• 3. Dissociative electron attachment to HGaF4 Lewis–Br?nsted superacid
  Marcin Czapla,Jack Simons Phys. Chem. Chem. Phys., 2018,20, 21739-21745
• 4. Evidence for the intrinsic nature of band-gap states electrochemically observed on atomically flat TiO2(110) surfaces?
  Shintaro Takata,Yoshihiro Miura Phys. Chem. Chem. Phys., 2014,16, 24784-24789
• 5. Fe(iii)-mediated isomerization of α,α-diarylallylic alcohols to ketones via radical 1,2-aryl migration?
  Ziyang Deng,Changwei Chen,Sunliang Cui RSC Adv., 2016,6, 93753-93755

Introduction to 1-(2-bromophenyl)methyl-5-methyl-1H-pyrazol-3-amine (CAS No. 1035223-67-6)

1-(2-bromophenyl)methyl-5-methyl-1H-pyrazol-3-amine is a significant compound in the field of pharmaceutical chemistry, characterized by its complex molecular structure and diverse potential applications. This compound, identified by the CAS number 1035223-67-6, has garnered attention due to its structural features and its role in the development of novel therapeutic agents. The presence of a bromine substituent at the 2-position of the phenyl ring and a methyl group at the 5-position of the pyrazole ring contributes to its unique chemical properties, making it a valuable intermediate in synthetic chemistry.

The pyrazole core is a heterocyclic aromatic compound that is widely recognized for its biological activity. Pyrazole derivatives have been extensively studied for their potential in various pharmacological applications, including antiviral, anti-inflammatory, and anticancer therapies. The specific substitution pattern in 1-(2-bromophenyl)methyl-5-methyl-1H-pyrazol-3-amine enhances its reactivity and functionality, enabling its use in the synthesis of more complex molecules.

In recent years, there has been a growing interest in developing small-molecule inhibitors targeting specific enzymes and receptors involved in disease pathways. The bromine atom in this compound serves as a versatile handle for further functionalization via cross-coupling reactions, such as Suzuki-Miyaura or Buchwald-Hartwig couplings. These reactions are pivotal in constructing biaryl structures, which are prevalent in many bioactive molecules. The methyl group at the 5-position of the pyrazole ring not only influences the electronic properties of the molecule but also plays a crucial role in determining its binding affinity to biological targets.

One of the most compelling aspects of 1-(2-bromophenyl)methyl-5-methyl-1H-pyrazol-3-amine is its potential application in drug discovery. Researchers have leveraged its structural motifs to design molecules with enhanced pharmacological profiles. For instance, studies have shown that pyrazole derivatives can modulate enzyme activity by acting as competitive inhibitors or by binding to allosteric sites. The bromophenyl moiety, in particular, has been found to improve metabolic stability and oral bioavailability, making it an attractive scaffold for drug development.

The synthesis of 1-(2-bromophenyl)methyl-5-methyl-1H-pyrazol-3-amine involves multi-step organic transformations, starting from readily available precursors. The key steps typically include bromination of a phenyl derivative, condensation reactions to form the pyrazole ring, and subsequent functionalization to introduce the methyl groups at appropriate positions. Advanced synthetic techniques, such as palladium-catalyzed cross-coupling reactions, have been employed to achieve high yields and purity levels.

The compound's potential is further highlighted by its role in developing next-generation therapeutics. For example, recent studies have explored its derivatives as kinase inhibitors, which are critical in treating cancers and inflammatory diseases. The ability to fine-tune the structure through strategic substitutions allows researchers to optimize potency and selectivity against specific disease targets. This flexibility makes 1-(2-bromophenyl)methyl-5-methyl-1H-pyrazol-3-amine a cornerstone in medicinal chemistry libraries.

In addition to its pharmaceutical applications, this compound has shown promise in materials science. Pyrazole derivatives exhibit unique electronic properties that make them suitable for use in organic semiconductors and light-emitting diodes (OLEDs). The bromine substituent enhances electron-withdrawing capabilities, which can be exploited to design materials with improved charge transport properties.

The ongoing research into 1-(2-bromophenyl)methyl-5-methyl-1H-pyrazol-3-amine underscores its significance as a building block for innovative chemical synthesis. As new methodologies emerge, the possibilities for modifying and expanding its utility continue to grow. Collaborative efforts between academia and industry are essential to fully harness its potential and translate laboratory findings into tangible benefits for society.

In conclusion, 1-(2-bromophenyl)methyl-5-methyl-1H-pyrazol-3-amine (CAS No. 1035223-67-6) represents a fascinating compound with broad applications across pharmaceuticals and materials science. Its unique structural features and reactivity make it an invaluable asset for researchers striving to develop novel therapeutics and advanced materials. As scientific understanding progresses, this compound is poised to play an increasingly pivotal role in shaping the future of chemical innovation.

• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)